Skip to main content

S. 3799

Reported by Committee

PREVENT Pandemics Act

Introduced 3/10/2022•117th Congress•Senate

Latest Action

Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.

3/15/2022 • Senate

Summary

Prepare for and Respond to Existing Viruses, Emerging New Threats, and Pandemics Act or the PREVENT Pandemics Act

This bill sets out programs and activities primarily to address public health preparedness and response.

Specifically, the bill establishes a legislative task force to investigate the COVID-19 pandemic and a White House office to advise on pandemic preparedness and response. It also revises authorities, programs, and other aspects of the Department of Health and Human Services and associated agencies to support preparedness and response activities at all levels of government.

Other matters addressed in the bill include

  • grants related to health disparities and for centers for public health preparedness;
  • collection and dissemination of public health data (e.g., genomic sequencing of pathogens);
  • workforce programs for public health and related fields;
  • the safety and availability of the blood supply;
  • research concerning viruses and other pathogens with pandemic potential, vaccines and other medical countermeasures, and the long-term health effects of COVID-19;
  • biosafety and security related to biological agents and toxins;
  • national security, privacy and information security, and foreign influence in biomedical research;
  • the administration of the Strategic National Stockpile; and
  • domestic manufacturing of medical countermeasures.

The bill also modifies the regulation of medical products with a particular focus on expediting the development and approval of medical countermeasures. Additional areas of focus include strengthening medical product supply chains and supporting innovation in, for example, clinical trial designs.

Introduced in Senate • 3/10/2022

Enter your district to see how this bill affects your community
-

Topics & Subjects

Policy Area: Health
Administrative law and regulatory proceduresAdvanced technology and technological innovationsAdvisory bodiesAgingAllied health servicesAsiaBlood and blood diseasesBusiness recordsCardiovascular and respiratory healthCenters for Disease Control and Prevention (CDC)Chemical and biological weaponsChild healthChinaCommunity life and organizationCongressional operations and organizationCongressional oversightCriminal investigation, prosecution, interrogationDepartment of Health and Human ServicesDigital media

Congressional Votes (0)

No recorded votes yet

Roll call votes will appear here as the bill moves through Congress

Related Federal Spending

Sponsor & Cosponsors (2)

Party Breakdown

1
Democrats
1
Republicans
0
Independents

Sponsor

S[
Sen. Murray, Patty [D-WA]

Democrat • WA

Sponsored 3/10/2022

Cosponsors (1)

S[
Sen. Burr, Richard [R-NC]

R-NC

Joined 3/10/2022

Bill Journey

Originated in the Senate

Introduced

March 10, 2022

Committee Review

March 15, 2022

Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.

Floor Debate

Passed Chamber

Other Chamber

President

Enacted into Law

Text Versions (1)

Introduced in Senate3/10/2022

Related Bills (28)

H.R. 5442

Fix Nondisclosure of Influence in Health Research Act

RelatedView bill →

H.R. 5478

Protecting the Integrity of our Biomedical Research Act of 2021

RelatedView bill →

H.R. 6305

Protect America’s Biomedical Research Enterprise Act of 2021

RelatedView bill →

H.R. 6980

To direct the Secretary of Health and Human Services to conduct a pilot program under which the Secretary increases the conduct of unannounced inspections of foreign human drug establishments and evaluates the differences between inspections of domestic and foreign human drug establishments, including the impact of announcing inspections to persons who own or operate foreign human drug establishments in advance of an inspection.

RelatedView bill →

S. 3394

Emergency Use Transparency Act

RelatedView bill →

S. 3449

Registration of Certain Foreign Establishments Act

RelatedView bill →

S. 3496

Promoting ACCESS to Diagnostics Act

RelatedView bill →

S. 3566

Improving Trauma Systems and Emergency Care Act

RelatedView bill →

S. 3569

HELP for Volunteers Act

RelatedView bill →

H.R. 5626

SAFE Biomedical Research Act

RelatedView bill →

H.R. 6363

Genetic Sequencing Accountability Act

RelatedView bill →

S. 3395

Medical Device Integrity Act

RelatedView bill →

S. 3476

SUPPORT Act

RelatedView bill →

S. 3477

PREVENT Medical Device Shortages Act of 2022

RelatedView bill →

S. 3479

Building a Sustainable Workforce for Healthy Communities Act

RelatedView bill →

S. 3493

Drug Shortages Shelf Life Extension Act

RelatedView bill →

S. 3506

Strengthening the Public Health Workforce Act

RelatedView bill →

S. 3534

Tracking Pathogens Act

RelatedView bill →

S. 3588

Medical Countermeasures Surge Capacity Act of 2022

RelatedView bill →

S. 3800

Centers for Public Health Preparedness and Response Reauthorization Act

RelatedView bill →

S. 3814

Modernizing Biosurveillance Capabilities and Epidemic Forecasting Act

RelatedView bill →

H.R. 7152

Tracking Pathogens Act

RelatedView bill →

S. 3834

A bill to strengthen medical device supply chains.

RelatedView bill →

H.R. 7669

Drug Shortages Shelf Life Extension Act

RelatedView bill →

H.R. 8151

Building a Sustainable Workforce for Healthy Communities Act

RelatedView bill →

H.R. 8163

Improving Trauma Systems and Emergency Care Act

RelatedView bill →

H.R. 8481

Improving DATA in Public Health Act

RelatedView bill →

S. 5327

National Task Force on the COVID-19 Pandemic Act

RelatedView bill →

Details

Bill TypeS
Current StatusReported by Committee
Cosponsors1